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cystic fibrosis transmembrane conductance regulator CYSTIC FIBROSIS (CF) IS a fatal disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Many epithelial tissues are affected in CF; however, patients usually succumb to respiratory failure that results from chronic infection and inflammation of the airways (22, 26) . The accumulation of abnormally thick mucus has long been considered to be a hallmark of the lung disease of CF, but the events leading from CFTR mutations to airway pathology remain poorly understood (22, 11) .
Accumulating evidence indicates that abnormal submucosal gland function contributes to CF airway disease (10, 17, 30) . Airway submucosal glands are a major source of mucus containing antimicrobial factors including lysozyme, lactoferrin, defensins, bicarbonate, and others that act synergistically to kill inhaled bacteria or inhibit their growth (8, 24, 33, 32) . Submucosal gland secretion is abnormal in CF airways. Glands from patients with CF, CFTRϪ/Ϫ and F508delCFTR piglets, and CFTRϪ/Ϫ ferrets and mice fail to respond to vasoactive intestinal peptide (VIP) or cAMP-elevating agents that would normally trigger mucus secretion (12, 15, 16, 28) . Wine and coworkers (5, 13, 34) proposed that this CFTR-mediated secretion by submucosal glands may be important in routine protection of the airways from near-constant inhalation of low levels of pathogens. In patients with CF, the loss of CFTR would disrupt this housekeeping function of the glands and may be one reason that pathogens may not be cleared from CF airways (5, 34) . However, whether the airway submucosal glands increase fluid secretion in response to inhalation of bacteria is unknown.
We studied the effect of two cytokines, interleukin-1␤ (IL-1␤) and tumor necrosis factor-␣ (TNF-␣), on fluid secretion by swine airway submucosal glands and the role of CFTR. These cytokines are released in response to P. aeruginosa infection and are elevated in CF airways (1, 20) . In addition, IL-1␤ has been shown to stimulate CFTR-mediated Cl Ϫ flux in Calu-3 cells, a model for submucosal gland serous cells (14) . Our results show that both IL-1␤ and TNF-␣ stimulate fluid secretion by submucosal glands that can be blocked by the CFTR inhibitor, CFTRinh172. Both cytokines seem to activate similar second messenger pathways because they do not have additive effects when applied simultaneously. IL-1␤ activates cAMP second messenger pathways, whereas intracellular Ca 2ϩ , cGMP, nitric oxide (NO), and p38 mitogen-activated protein (p38 MAP) kinase do not play major roles.
MATERIALS AND METHODS
Swine trachea preparation. Pig tracheae and lungs were obtained from juvenile female and male Yorkshire pigs weighing 15-25 kg following euthanasia for other purposes. The trachea and major bronchi were dissected within 15-30 min of euthanasia and placed in ice-cold Krebs-Ringer bicarbonate buffer (mmol/l): 115 NaCl, 2.4 K 2HPO4, 0.4 KH2PO4, 1.2 CaCl2, 1.2 MgCl2, 25 NaHCO3, 10 glucose (pH ϭ 7.4) equilibrated with 95% O 2-5% CO2 and used for experimentation within 1 h. Because the viability of the tissue declines with time, we did not keep the tissue for more than 30 h after euthanasia. To minimize tissue exposure to endogenously generated prostaglandins during tissue preparation, mounting and experimentation, 1.0 M indomethacin was present in the bath throughout. All procedures were approved by the Animal Care Committee of the University of Saskatchewan.
Secretion assay. We used the secretion assay developed by Quinton (23) as explained elsewhere (12) . Briefly, the mucosal layer from trachea or primary bronchus, with underlying glands, was dissected from the cartilage. A piece of tissue of about 1 cm 2 was pinned mucosal side up and mounted in a 35-mm-diameter plastic Petri dish lined with Sylgard (Dow Corning Corp). The serosal side was im-mersed in a bathing solution (ϳ1 ml volume), and the mucosa was in air. Before experimentation, the mucosal surface was gently cleaned and blotted dry with cotton swabs and further dried with a stream of air, after which 20 -30 l of water-saturated mineral oil was placed on the surface. The preparation was then placed in a temperaturecontrolled chamber (TC-324B; Warner Instruments, Hamden, CT) maintained at 37°C and equilibrated with warmed, humidified 95% O 2-5% CO2. Pharmacological agents were diluted to final concentrations with warmed bath solution equilibrated with 95% O2-5% CO2. They were added to the serosal side by complete bath replacement.
Droplets of mucus form under oil during secretion by individual submucosal glands. Images of the lumen of the trachea were taken at 2-min intervals using a digital camera (MiniVid; LW Scientific, Lawrenceville, GA) and stored for offline analysis. Stored images were analyzed using ImageJ 1.32J (NIH). Secretion volumes were calculated, as previously described, by assuming the mucus droplet to be spherical. Then V ϭ 4/3 r 3 , where r is the radius (12) . The following inclusion criteria for individual droplets were used: 1) circular outline so that a spherical shape could be assumed;, 2) clear edges to allow accurate measurement of the radius, and 3) no fusion with neighboring droplets. Viability of the preparation was tested at the end of each experiment by measuring the response to carbachol. Nonresponding glands (Ͻ5%) were excluded from the analysis. The secretion rate was calculated by fitting the volume vs. time plots using linear regression, and the slopes were taken as the secretion rates using at least four points. The r 2 value for such linear fits was Ͼ0.8. Reagents. Stock solutions of IL-1␤, TNF-␣, NG-nitro-L-arginine methyl ester hydrochloride (L-NAME), 2-(4-carboxyphenyl)Ϫ4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (cPTIO), and carbachol were dissolved directly in Krebs-Ringer solution. Indomethacin, bumetanide, forskolin, KT5823, IBMX, SQ22536, and CFTRinh172 stocks were prepared in DMSO. The final DMSO concentration did not exceed 0.1%, a concentration that did not affect fluid secretion to carbachol during control experiments (data not shown). Reagents were obtained from Sigma (St. Louis, MO), CFTRinh172 was obtained from Calbiochem (Darmstadt, Germany); L-NAME, cPTIO, KT5823, IL-1␤, and TNF-␣ were obtained from R & D Systems (Minneapolis, MN).
Statistics. Data are presented as means Ϯ SE, and the sample size (n) indicates the number of individual preparations. Each data point is obtained by averaging the individual glands in each preparation. Data were analyzed using parametric or nonparametric statistics, as appropriate, using GraphPad Prism 4 (GraphPad Software, San Diego, CA). Nonlinear regressions were performed using GraphPad Prism 4 (GraphPad Software). Significance was set at P Ͻ 0.05.
RESULTS

IL-1␤ and TNF-␣ stimulate CFTR-dependent fluid secretion.
Treatment with 50 ng/ml IL-1␤ stimulated fluid secretion by submucosal glands (Fig. 1, A and B) . Secretion rate increased from 60 Ϯ 25 to 260 Ϯ 30 pl/min after stimulation with IL-1␤ (Fig. 1B) . Preparations that were preincubated with the CFTR inhibitor, CFTRinh172 (100 mol/l) had a smaller response to IL-1␤ (Fig. 1, A and B) .
Similarly, TNF-␣ (50 ng/ml) stimulated fluid secretion by airway submucosal glands ( In addition to the CFTR-dependent fluid secretion, airway submucosal glands are also capable of secreting fluid through a pathway that involves niflumic acid-sensitive Ca 2ϩ -activated Cl Ϫ channels (12, 30) . Thus we tested the effect of niflumic acid on IL-1␤-stimulated fluid secretion. Treatment with 1 mol/l niflumic acid had no effect on IL-1␤-stimulated fluid secretion ( Fig. 2A) . Fluid secretion rate increased from 20 Ϯ 10 pl/min before stimulation to 130 Ϯ 10 and 250 Ϯ 70 pl/min after stimulation with IL-1␤ or IL-1␤ plus niflumic acid, respectively (Fig. 2B) . IL-1␤-stimulated fluid secretion was sensitive to treatment with the Na ϩ :K ϩ :2Cl Ϫ contransporter . Taken together, these results suggest that the cytokines stimulate Cl Ϫ transport through a mechanism that involves CFTR and NKCC, but it is independent of niflumic acidsensitive Ca 2ϩ -activated Cl Ϫ channels. The effect of IL-1␤ and TNF-␣ showed a concentration dependency that could be fitted using three parameter concentrationresponse curve by nonlinear regression (Fig. 3, A and B) . The half maximal effective concentrations (EC 50 ) were 10.8 and 19.6 ng/ml for IL-1␤ and TNF-␣, respectively. Maximum secretion rate (V max ) was 240 Ϯ 20 and 190 Ϯ 40 pl/min for IL-1␤ and TNF-␣, respectively. The best-fit curves for stimulation with IL-1␤ and TNF-␣ did not differ significantly (F test, P Ͼ 0.8). Thus the EC 50 and V max for both cytokines were not significantly different, suggesting that both cytokines may stimulate similar pathways.
To study whether IL-1␤ and TNF-␣ act on similar stimulatory pathways, we tested whether they have an additive effect on fluid secretion. Simultaneous stimulation with IL-1␤ and TNF-␣, both at a concentration of 50 ng/ml, did not produce more mucus than IL-1␤ alone (Fig. 4A) . The fluid secretion rates for IL-1␤ (240 Ϯ 50 pl/min), TNF-␣ (260 Ϯ 90 pl/min), and IL-1␤ plus TNF-␣ (210 Ϯ 70 pl/min) were not significantly different either (Fig. 4B) . Taken together, the results indicate that IL-1␤ and TNF-␣ stimulate similar ion transporters (i.e., CFTR and NKCC), have similar EC 50 and V max , and do not have an additive effect on secretion rate. These data suggest that both cytokines elicit similar responses.
Intracellular second messenger pathways. CFTR-dependent submucosal gland secretion is stimulated by cAMP; thus we tested the role of cAMP in IL-1␤-stimulated fluid secretion. Stimulation of submucosal glands with the cAMP-elevating agent, forskolin (10 mol/l), increased fluid secretion. Subsequent addition of IL-1␤ (50 ng/ml) did not further increase fluid secretion (Fig. 5A ). The secretion rates obtained by stimulation with forskolin or forskolin plus IL-1␤ were 320 Ϯ 70 pl/min and 300 Ϯ 40 pl/ min, respectively. These secretion rates were not significantly different (Fig. 5B) . Inhibition of adenylate cyclase with the blocker SQ22536 (0.5 mmol/l) reduced fluid secretion by IL-1␤-stimulated submucosal glands from 130 Ϯ 30 to 40 Ϯ 5 pl/min, whereas treatment with the phosphodiesterase inhibitor IBMX (1 mmol/l) increased fluid secretion to 230 Ϯ 40 nl/min (Fig. 5, C and D) .
There is evidence that cAMP stimulation may induce the production of cGMP (21) . Because cGMP has been shown to modulate the function of CFTR in submucosal glands and Calu-3 cells, we tested the role of cGMP-dependent protein kinase on IL-1␤ stimulation (3). Preincubation of glands with the cGMP-dependent protein kinase inhibitor KT5823 (1 mol/l) did not reduce secreted volume of IL-1␤-stimulated fluid secretion (Fig. 6, A and B) . Similarly, KT5823 did not have any effect of forskolin-stimulated secretion, suggesting that cGMP is not involved in IL-1␤-or forskolin-stimulated secretion (Fig. 6, C and  D) . Taken together the data suggest that IL-1␤ stimulates submucosal gland secretion via adenylate cyclase and cAMP production.
There is evidence that CFTR-dependent fluid secretion by swine glands may be stimulated through mechanisms that include increasing intracellular Ca 2ϩ (4, 17) . We tested the possible role that intracellular Ca 2ϩ may play in IL-1␤-stimulated fluid secretion by incubating the glands in Ca 2ϩ -free saline containing the Ca 2ϩ chelator BAPTA-AM (500 mol/l). Fluid secretion rate was 127 Ϯ 26 pl/min and 74 Ϯ 14 pl/min for control glands and those preincubated in Ca 2ϩ -free plus BAPTA-AM, respectively. However, this was not significantly different (Fig. 7, A and B) .
The IL-1␤-triggered response appears to involve p38 MAP kinase in Calu-3 and airway cells (14, 27, 36 ). Thus we tested the effect of p38 blocker, SB202190 (1 mol/l) on IL-1␤- /l) , on IL-1␤-stimulated mucus secreted volume (A, 2-way repeatedmeasures ANOVA, IL-1␤, n ϭ 12, and IL-1␤ ϩ niflumic acid, n ϭ 6) and secretion rate (B, ANOVA, P Ͻ 0.05, Student-Newman-Keuls multiple comparison, n ϭ 18, 12, and 6 preparations for baseline, Il-1␤ and Il-1␤ ϩ niflumic acid, respectively). C and D: effect of the NKCC blocker, bumetanide (1 mol/l) (C, 2-way repeated-measures ANOVA, Bonferroni posttest, P Ͼ 0.05, IL-1␤, n ϭ 7 and IL-1␤ ϩ bumetanide n ϭ 8). The asterisks indicate significant difference between the 2 groups. Bumetanide reduced fluid secretion rate (D, P Ͻ 0.05, ANOVA, Student-Newman-Keuls multiple comparison, n ϭ 8, 7, and 8 preparations for baseline, Il-1␤ and Il-1␤ plus bumetanide, respectively). Columns marked with different letters indicate significant differences. stimulated submucosal gland secretion. Fluid secretion rate was 126 Ϯ 15 pl/min and 71 Ϯ 6 pl/min for control glands and those preincubated with SB202190, respectively. However, the effect was not statistically significant (Fig. 7) .
IL-1␤ stimulation of culture cardiocytes and ␤-cells from rodent islets of Langerhans induces the formation of NO (7, 31) . In addition, NO has been implicated in modulation of submucosal gland secretion (19, 29) . To study the role of NO, we tested the effect on IL-1␤ stimulation of the NO synthase (NOS) inhibitor, L-NAME, as well as the NO scavenger, cPTIO. Neither L-NAME (100 mol/l) nor cPTIO (3 mol/l) blocked IL-1␤-stimulated secretion by submucosal glands (Fig. 8) , suggesting that NO does not play a significant role on IL-1␤-stimulated secretion.
DISCUSSION
The key finding of our studies is that both IL-1␤ and TNF-␣ stimulate CFTR-dependent fluid secretion by airway submucosal glands. This is the first report that cytokines stimulate CFTR-dependent fluid secretion by airway submucosal glands, suggesting that CF airways would fail to respond appropriately to bacteria, facilitating infection.
IL-1␤ and TNF-␣ stimulate submucosal gland fluid secretion. The mechanism of fluid transport by cytokine-stimulated glands is similar to those triggered by VIP and forskolin. Fluid secretion was reduced by treatment with bumetanide and CFTRinh172, suggesting the involvement of a basolateral Na ϩ :K ϩ :2Cl Ϫ contransporter and apical CFTR. Moreover, the fluid secretion was insensitive to niflumic acid, suggesting the Ca 2ϩ -activated Cl Ϫ channels are not involved in cytokinestimulated secretion (5, 12, 16, 17) .
The maximal secretion rate stimulated by the cytokines was lower than that stimulated by 10 M forskolin, VIP (1,580 pl/min, 4), SP (4,120 pl/min, 17) and carbachol (3,550 pl/min, 4). The secretion rate stimulated by cytokines was similar to that reported for capsaicinoids-stimulated submucosal gland preparations of 460 pl/min (17) and 300 pl/min (4) in pig and humans, respectively. However, the fluid secretion stimulated by IL-1␤ and TNF-␣ may be larger in vivo. Recent reports have shown that nociceptors in the airways express receptors for IL-1␤ and TNF-␣ and are stimulated by cytokines. C-fibers respond to stimulation with IL-1␤ and TNF-␣ by increasing their electrical activities and vagal afferent activity (18, 35, 37) . Submucosal glands are stimulated by C-fibers throughout axon reflex and anterograde release of the neurotransmitter substance P and, possibly, VIP and Ach (5, 12, 17) . Thus one would expect that the production and release of IL-1␤ and TNF-␣ in response to inhalation of bacteria would result in a larger fluid secretion response than that reported here. Fig. 3 . IL-1␤ and TNF-␣ display a concentration-dependent effect on submucosal gland secretion. IL-1␤ (A) and TNF-␣ (B) were fitted with a 3-parameter logistic curve using nonlinear regression (n ϭ 6 or 7 preparations for each point). The half maximal concentrations for stimulation (EC50) were 10.8 and 19.6 ng/ml for IL-1␤ and TNF-␣, respectively. Maximum secretion rates (Vmax) were 240 Ϯ 20 and 190 Ϯ 40 pl/min for IL-1␤ and TNF-␣, respectively. The best-fit curves for stimulation with IL-1␤ and TNF-␣ did not differ significantly (F test, P Ͼ 0.8). Fig. 4 . IL-1␤ and TNF-␣ do not have additive effects. A: secreted volume produced by glands stimulated with IL-1␤ alone (OE, n ϭ 13) or both TNF-␣ plus IL-1␤ (, n ϭ 8) did not differ significantly (2-way repeated-measures ANOVA). B: secretion rate stimulated by the IL-1␤ (50 ng/ml, n ϭ 33), TNF-␣ (50 ng/ml, n ϭ 13), or TNF-␣ ϩ IL-1␤ simultaneously (both 50 ng/ml, n ϭ 8) was not significantly different (1-way ANOVA).
More research is required to determine the interaction between the immune and nervous system in the response to inhalation of bacteria.
The intracellular second messenger pathway. Our results indicate that IL-1␤ stimulation involves cAMP/PKA, consistent with reports in osteoarthritic chondrocytes and human pulmonary artery smooth muscle cells (2, 9) . IL-1␤-stimulated fluid secretion by submucosal glands was not significantly reduced by buffering Ca 2ϩ , blockage of NO or cGMP-dependent protein kinase, or inhibition of p38 MAP kinase. These results contrast with those published in Calu-3 cells, where p38 MAP kinase pathways were involved in IL-1␤-stimulated CFTR-dependent Cl Ϫ currents (14) . These results also contrast with previous measurements in Calu-3 cells showing that IL-1␤ affected cAMP and Cl Ϫ permeability differentially when added together with either prostaglandin E2 or isoproterenol (6) . The contradictions may result from differences in the transport machinery expressed in Calu-3 compared with the native tissue. Calu-3 cells lack chromosomes 1, 13, 15, and 17, and is triploid for some other unidentified chromosomes; thus some genes may be missing or have altered expression (25) . In any case, it is clear that cAMP/PKA is the major signaling pathway mediating cytokine-stimulated secretion in swine tracheal glands.
Significance for CF. The data presented here provide the first demonstration that airway submucosal glands increase CFTRmediated secretion in response to proinflammatory signals. Our results support the hypothesis that bacteria-triggered gland secretion is part of the normal innate immune response involved in housekeeping against routine, low-level bacteria inhalation (14, 34) . This response could be crucial to inactivating, killing, and clearing P. aeruginosa recently acquired from the environment before the bacteria can replicate. In patients with CF, inhalation of bacteria would trigger production and release of proinflammatory cytokines, but the secretion of mucus by airway submucosal glands would be missing, thus facilitating infection and inflammation. . C: preincubation in nitro-L-arginine methyl ester (L-NAME) (100 mol/l) does not block IL-1␤-stimulated secretion (2-way repeated-measures ANOVA, IL-1␤, n ϭ 6, and IL-1␤ ϩ L-NAME, n ϭ 9). D: IL-1␤-stimulated secretion rate is not blocked by the cPTIO (Kruskal-Wallis test, Dunn's multiple-comparison test, n ϭ 23, 6, 9 for baseline, IL-1␤ and IL-1␤ ϩ L-NAME, respectively). Columns marked with different letters indicate significant difference between groups.
